Skip to content

6-KAccepted May 26, 4:35 PM ET

NERVGEN PHARMA CORP. 6-K

NGENNERVGEN PHARMA CORP.

sec.gov(opens the filing on sec.gov)View full filing

Accepted (ET)

4:35 PM

May 26, 2026

Filed

May 26, 2026

Documents

3

Size

49.5 KB

Summary

Summary not available

This filing does not have a written summary yet. You can still open the original filing and its exhibits.